|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||0.00 / 0.00|
When a stock is hitting new 52-week highs, it often means that the uptrend is very strong and the buyers are in full control.
University College Dublin (UCD) and Elan Corporation plc, (NYSE: ELN) today announced an initiative designed to create a leadership position in the global biotechnology industry.
The five nominees for Worst Biotech CEO of 2011 face the wrath of readers; one of whom will get tagged with this dishonorable award.
Elan Corporation, plc (NYSE: ELN) today provides an update on ELND005 (Scyllo-inositol).
The University of Cambridge and Elan Corporation plc. (NYSE: ELN) today announced the launch of The Cambridge-Elan Centre for Research Innovation and Drug Discovery (Cambridge-Elan Centre), which will be located at...
Elan Corporation, plc today reported its third quarter and first nine months 2011 financial results.
Today Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) announced that the U.
Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) today announced 28 company-supported TYSABRI ® (natalizumab) presentations at the 5 th Joint Triennial Congress of the European and...
Elan Corporation, plc (“Elan”) (NYSE: ELN) announced today the expiration and final results of the previously announced offers to purchase of the senior notes issued by Elan’s wholly-owned subsidiaries, ...
Elan Corporation, plc (NYSE:ELN) announced today that it will host a conference call on Thursday October 27 th, 2011 at 8:30 a.
Elan Corporation, plc (“Elan”) (NYSE: ELN) announced today that it has commenced planned measures to reduce its indebtedness using the cash proceeds received in connection with the combination of its EDT business...
Alkermes plc (NASDAQ: ALKS) and Elan Corporation, plc (NYSE: ELN) (“Elan”) today announced the completion of the merger between Alkermes, Inc.
Elan Corporation, plc today announced that Dr. Andrew von Eschenbach and Mr.
Biotech stocks that can help investors weather the S&P downgrade of American's credit rating and the ensuing market sell off.
Poor trial results from one drug undermine several other treatments in the pipeline from various companies.
Elan Corporation, plc today reported its second quarter and first half 2011 financial results.
Biogen profit fell in the second quarter but a reinvigorated multiple sclerosis drug Tysabri recorded strong sales.
Alkermes tells investors what to expect once its merger closes with Elan Drug Technologies.
Elan Corporation, plc (NYSE:ELN) announced today that it will host a conference call on Wednesday July 27 th, 2011 at 8:30 a.
Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) announced today that the European Commission (EC) has approved the inclusion of anti-JC virus (JCV) antibody status as an additional factor to...
Elan Corporation, plc (NYSE: ELN) announced today that it will present at the Jefferies 2011 Global Healthcare Conference on Tuesday, June 7th at 9:30am Eastern Time and 2:30pm British Summer Time.
Proteostasis Therapeutics (“Proteostasis”) and Elan Corporation (NYSE: ELN) today announced a strategic business relationship to advance Proteostasis’ platform for the discovery and development of ...
Tyson shares were up slightly in premarket trading after coming in shy on the bottom line, but beating on the top line.
Stock futures are pointing to a stronger open Monday amid Greece debt concerns and rising commodities.
Alkermes reached a deal to acquire Elan Drug Technologies from Elan, the Irish drugmaker, for $960 million in cash and stock.
Alkermes, Inc. (NASDAQ: ALKS) and Elan Corporation, plc (NYSE: ELN) today announced the execution of a definitive agreement under which Alkermes will merge with Elan Drug Technologies (EDT), the profitable,...
Elan Corporation, plc, today reported its first quarter 2011 financial results.
As we try to sort out recent market events, here are a few technical setups to keep an eye on.
Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) today announced that the Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for inclusion of an additional...
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.